Clinical Trial

Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE

Name: Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE — clinical trial record (NCT07233642)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated November 18, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.

Summary

This is an investigator-initiated trial aimed at assessing the safety and efficacy of ultra-fast autologous CD19-targeted CAR-T cells in the treatment of refractory systemic lupus erythematosus.

Trial Details

NCT Number	NCT07233642
Lead Sponsor	The Children's Hospital of Zhejiang University School of Medicine
Conditions	Systemic Lupus Erythematosus
Enrollment	18 participants
Start Date	2025-11
Primary Completion	2026-05 (estimated)
Study Completion	2028-09 (estimated)
Updated on ClinicalTrials.gov	2025-11-18